Fig. 3.
Pooled estimate (OR) of severe/critical illness associated with the use of ACEIs/ARBs. Heterogeneity: I2 = 66%; p = 0.001. ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, CI confidence interval, OR odds ratio
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.